Elexacaftor/Tezacaftor/Ivacaftor Markedly Reduces <i>Aspergillus fumigatus</i> in Cystic Fibrosis
Sarah J. Morgan, David P. Nichols, Wendy Ni, Gina Hong, Stephen J. Salipante, George M. Solomon, Steven M. Rowe, John Clancy, Robert A. Cramer, Pradeep K. Singh
Topics & Concepts
IvacaftorMedicineCystic fibrosisAspergillus fumigatusIntensive care medicineInternal medicineImmunologyCystic fibrosis transmembrane conductance regulatorCystic Fibrosis Research AdvancesAntifungal resistance and susceptibilityNematode management and characterization studies